From AI-assisted tuberculosis screens in rural clinics to cancer biobanks training deep learning models at AIIMS, artificial intelligence is quietly rewriting how 1.4 billion Indians are diagnosed, monitored, and healed.
$18.5B
Projected India Healthcare AI Market by 2035
27.7%
CAGR Growth Rate 2025–2035
282M
Telemedicine consultations via eSanjeevani (Apr 2023–Nov 2025)
It’s 6 a.m. in a primary health centre in Vidarbha, Maharashtra. A 52-year-old farmer walks in for what he thinks is a routine chest check-up. The nurse runs a quick X-ray. Within minutes, an AI model flags a suspicious shadow — a potential early-stage tuberculosis lesion that a human radiologist, reviewing hundreds of images a day, might have deferred to tomorrow. This is not a vision of the distant future. It is India’s healthcare reality in 2026.
Artificial intelligence is no longer a pilot project or a PowerPoint promise. Across public hospitals, rural clinics, premier medical institutions, and a booming startup ecosystem, AI-powered diagnostics are becoming embedded in how India detects, tracks, and treats disease.
By the Numbers
India’s healthcare AI market was valued at $1.26 billion in 2024 and is projected to soar to $18.55 billion by 2035 — growing at a compound annual rate of 27.7%. Diagnostics is the single largest segment of this market, and predictive analytics is the fastest growing.
The Scale of the Problem AI Is Solving
India faces a formidable healthcare paradox: a population of 1.4 billion, a doctor-to-patient ratio far below the WHO-recommended benchmark, and a disease burden that includes the world’s highest TB caseload(26.18L), 77 million diabetics, and a rapidly growing cancer incidence. Specialist doctors are concentrated in metro cities. Rural India — home to nearly 65% of the population — often has no access to radiologists, cardiologists, or oncologists at all.
This is precisely where AI becomes not just helpful, but transformational. AI doesn’t need to travel. It doesn’t sleep. And it scales infinitely.
What’s Actually Happening on the Ground
India’s AI healthcare story is no longer just about ambition. Real deployments are scaling fast, with measurable impact.
Tuberculosis
Cough Against TB(CATB) — AI Listens to Detect Disease
Deployed under India’s National TB Elimination Programme, AI tools now enable non-specialist health workers to perform high-level TB screenings. The result: a 27% decline in adverse TB outcomes recorded between 2022 and 2025.
Diabetic Retinopathy
MadhuNetrAI — Saving Eyesight at Scale
Launched in December 2025, MadhuNetrAI became India’s first AI-assisted community screening programme for diabetic retinopathy, reaching over 7,100 patients across 38 healthcare facilities in just months.
Eye Disease
Nayanamritham 2.0, Kerala
In February 2025, Kerala became the first Indian state to launch a government-led AI-assisted eye disease screening programme, using Remidio’s portable AI devices to detect glaucoma and age-related macular degeneration.
Cancer Detection
NITI Aayog’s Cancer Imaging Biobank
Building a database of over 20,000 patient profiles filled with radiology and pathology images, this project trains AI to spot cancer earlier and assist doctors in personalising treatment plans, a crucial step in fighting India’s rising cancer burden.
The Indian Startups Leading the Charge
India’s AI diagnostics ecosystem is driven in no small part by a new generation of healthtech companies that are attracting global attention.
Qure.ai, the Mumbai-based startup, has developed AI-powered chest X-ray and CT scan interpretation tools now deployed across multiple countries. Its algorithms aid in the early detection of tuberculosis, lung diseases, and neurological disorders — and can return results in seconds rather than hours.
Niramai Health Analytix is pioneering non-invasive, AI-powered breast cancer screening using thermography — an approach that is both radiation-free and low-cost, making it far more accessible than traditional mammography in rural and semi-urban India.
Tricog Health has deployed AI-powered ECG analysis to detect heart attacks early, with interpretations delivered to cardiologists in real-time, even from clinics in Tier-3 cities. Remidio, with its AI-enabled portable retinal imaging devices, is addressing a silent crisis: India accounts for 12 million glaucoma patients, of whom over 90% remain undiagnosed.
Wadhwani AI, a non-profit AI institute, is developing multi-disease screening tools at AIIMS for diabetic retinopathy, pulmonary conditions, and skin diseases — solutions now being scaled nationally through the AIIMS Centre of Excellence in collaboration with the Ministry of Health.
Key Research Finding
Studies in 2025 show AI diagnostic tools achieve accuracy rates between 76% and 90% in imaging and clinical analysis, and in cancer diagnostics specifically, AI-powered tools have reached a 93% match rate with expert tumour board recommendations.
Government’s Big Bet on AI Health
This isn’t a private sector story alone. The Indian government has made AI in healthcare a national priority, backed by serious institutional commitment and funding.
The IndiaAI Mission, approved in March 2024 with a financial allocation of ₹10,371.92 crore, has healthcare AI as one of its primary focus areas. Under its Application Development Initiative, multiple healthcare AI solutions have been shortlisted, covering cancer screening, maternal health, and disease surveillance.
In March 2025, AIIMS Delhi, PGIMER Chandigarh, and AIIMS Rishikesh were officially designated as Centres of Excellence for Artificial Intelligence — tasked with developing indigenous AI solutions tailored to India’s specific disease patterns and population demographics. The National Health Authority also inked an MoU with IISc Bengaluru’s healthcare AI centre for advancing R&D in the space.
The digital foundation supporting all of this is the Ayushman Bharat Digital Mission (ABDM). As of August 2025, 799 million digital health IDs have been created, over 410,000 healthcare facilities are registered on digital repositories, and 671 million health records are linked to Ayushman Bharat Health Accounts. This interoperable data infrastructure is the substrate that AI models need to truly learn and perform at scale.
In early 2026, the Ministry of Health launched the Strategy for AI in Healthcare in India (SAHI), a comprehensive framework focused on ethical, evidence-based AI deployment. Alongside it, the Central Drugs Standard Control Organisation (CDSCO) has classified AI imaging tools such as CT and MRI interpretation systems as Class C medical devices, requiring formal clinical validation before hospital deployment — signalling that India is maturing from enthusiasm to governance.
What Experts Are Saying
Voices Shaping India’s AI Health Future
Speaking at the Health of India Summit 2026, Dr. Barnwal emphasised that building Indian datasets is crucial for developing accurate disease prediction models tailored to the country’s diverse population — and announced the upcoming launch of India’s National AI Strategy for Health to create a roadmap for responsible AI deployment in healthcare.
“India accounts for 12 million glaucoma patients, nearly one in eight globally. Yet over 90 per cent of these cases remain undiagnosed, often leading to irreversible vision loss. Early detection using portable, AI-enabled tools can drastically change this trajectory.”
“What makes AI particularly valuable is its ability to quickly process large volumes of data and identify patterns that might be missed during routine evaluations. As the technology evolves, AI is expected to become a standard part of maternal care — not just in well-equipped hospitals, but also in remote and underserved areas via mobile health tools and wearable devices.”
Shah has been emphatic that while 2025 was the year of intent, 2026 must be the year of implementation. Success in India’s healthcare transformation, she argues, will not be measured by financial growth or technology adoption alone — but by tangible, measurable improvements in patient outcomes, especially for the underserved.
The R&D Frontier: What Labs Are Building Next
India’s research institutions are not just deploying existing AI — they are building the next generation of diagnostic tools suited to Indian conditions.
Federated Learning is emerging as a breakthrough approach: AI models are trained across multiple hospitals’ datasets simultaneously, without any individual patient’s data leaving its source institution. This allows model accuracy to improve across thousands of cases while fully protecting privacy — a critical design choice in a country where trust in digital health data remains a work in progress.
The MafPro device — a handheld, AI-powered, radiation-free tool — is being developed to detect whether cancer has spread to lymph nodes, enabling non-invasive staging of tumours that previously required surgery or biopsies. Combined with NITI Aayog’s cancer imaging biobank, these tools represent the kind of home-grown innovation that India is betting will define the next decade.
At the wearables frontier, the IndiaAI Mission is funding development of AI-based wearable diagnostic devices that can continuously monitor vitals and flag deterioration before it becomes critical — think of it as a 24/7 AI doctor for patients with chronic conditions. Cloud-based radiology platforms are also being developed to connect pathology labs in Tier-2 cities with AI interpretation engines and specialist doctors in real time.
Acculi Labs and similar startups are integrating AI with mobile-based diagnostic kits to deliver affordable, portable blood testing and infection detection in rural areas — without the need for specialised lab technicians. The smartphone, it turns out, is India’s most democratic health device.
Innovaccer Developer of a healthcare intelligence platform for data aggregation and analysis. The platform unifies disparate data sources to provide actionable insights and enhance healthcare outcomes. It offers solutions for value-based care, population health management, and provider engagement. The platform also provides tools for care management, referral management, and financial performance analysis. The platform also offers data activation, an AI engine, and applications for value-based care, population health, and provider engagement.
Eka Care Provider of AI-powered EMR, EHR, and patient engagement solutions. The solutions streamline operations and enhance patient care for doctors and hospitals. A developer platform allows for the creation of healthcare solutions using AI-enhanced tools. It provides an intelligent clinical assistant that leverages artificial intelligence to streamline medical documentation, provide patient insights, and enhance clinical decision-making through voice-enabled features and automated documentation capabilities.
Doceree Provider of an AI-powered operating system for healthcare marketing solutions. The system offers intelligence, reading, conversation, workflow, and experience layers to enhance interactions. It provides insights, audience activation, and content matching across specialist medical publishers. The system delivers real-time answers and personalized messages within clinical workflows. It also orchestrates campaigns and tracks journeys.
SigTuple Healthcare technology company that leverages AI to develop diagnostic solutions. It is a healthcare technology company that leverages artificial intelligence, robotics, and cloud computing to develop intelligent screening solutions for medical diagnostics. The company’s products are designed to automate microscopy and enable AI-assisted digital analysis of visual medical data, making quality healthcare more accessible and affordable.
The Honest Reckoning: Challenges That Cannot Be Ignored
The promise is real, but so are the obstacles. Experts consistently flag a cluster of challenges that could slow or distort AI’s healthcare impact if left unaddressed.
Current Challenges
- High implementation costs block adoption in smaller hospitals and rural clinics
- Data privacy concerns — patients often unaware how their medical data is used in AI training
- Algorithmic bias if models are trained on non-representative datasets that miss India’s demographic diversity
- Lack of standardisation in AI regulations across institutions adds compliance complexity
- Limited AI infrastructure and digital literacy in rural healthcare facilities
- Shortage of trained professionals who can work effectively alongside AI systems
Diabetic Retinopathy
- Digital Personal Data Protection (DPDP) Act 2023 strengthening data security frameworks
- CDSCO’s new classification of AI imaging tools as Class C devices requires clinical validation
- SAHI framework (2026) providing ethical guidelines for AI deployment
- Federated learning protecting patient privacy while improving model accuracy
- Cloud-based AI solutions reducing hardware costs for smaller facilities
- IndiaAI Mission funding reskilling programmes for healthcare AI professionals
Looking Ahead: The Road to 2030
India’s AI healthcare journey is accelerating in both ambition and reality. The country is funding a $12 billion research fund and project-based assistance under the PRIP scheme for pharma and MedTech innovators. Global technology giants are setting up Global Capability Centres in India specifically to develop healthcare AI models.
The eSanjeevani telemedicine platform — which has now facilitated 282 million consultations, of which 12 million included AI-assisted diagnostic recommendations — is set to deepen its AI integration. AI-powered Clinical Decision Support Systems (CDSS) are already helping general practitioners in remote areas make decisions that previously required a specialist’s judgment.
The government is also backing AI with over $1 billion in dedicated funds for closing specialist access gaps, particularly in Tier-II and Tier-III cities, where the majority of India’s undiagnosed chronic disease burden sits.
By 2030, analysts project that AI-powered disease prediction platforms, smart hospital monitoring systems, personalised treatment recommendations, and automated medical imaging will all be standard — not exceptional — features of Indian healthcare delivery.
Conclusion: Not a Question of If, But How
The debate about whether AI belongs in Indian healthcare is over. It is already there — in AIIMS radiology wards, in Kerala’s eye screening vans, in the encrypted health IDs of nearly 800 million citizens, and in the chest X-ray algorithm that caught a farmer’s TB shadow before it became a death sentence.
The question now is how well India manages the transition: how thoughtfully it builds its data infrastructure, how carefully it trains its health workforce, how rigorously it validates AI algorithms against India’s unique population, and how equitably it ensures that the benefits of this revolution reach not just urban hospitals, but every primary health centre in every district of this vast, diverse, and medically underserved nation.
If India gets that right, AI healthcare diagnostics won’t just be a market story. It will be a public health transformation — one detected early enough to actually change outcomes.
Official References
National Health Authority (India): nha.gov.in · IndiaAI Mission: indiaai.gov.in · Press Information Bureau: pib.gov.in
